Home / Inspections / 926019

FDA Inspection 926019 — Danny H. Sugimoto, M.D.

Danny H. Sugimoto, M.D. — FEI 3007207764

The FDA completed an inspection of Danny H. Sugimoto, M.D. on May 20, 2015 in Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 20, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chicago, IL (United States)

Additional Details

Clinical Investigator (CI)

Facility

Other inspections at this facility

  • 1092841 (NAI Thu May 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923844 (VAI Wed May 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 860826 (VAI Thu Jan 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 571974 (VAI Mon Feb 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources